Ciprofloxacin-Resistant Pseudomonas aeruginosa Lung Abscess Complicating COVID-19 Treated with the Novel Oral Fluoroquinolone Delafloxacin

PURPOSE: We report the development of a lung abscess caused by a ciprofloxacin-resistant Pseudomonas aeruginosa in a patient with COVID-19 on long-term corticosteroid therapy. Successful antimicrobial treatment included the novel oral fluoroquinolone delafloxacin suggesting an oral administration op...

Descripción completa

Detalles Bibliográficos
Autores principales: Panholzer, Jürgen, Neuboeck, Matthias, Shao, Guangyu, Heldt, Sven, Winkler, Markus, Greiner, Paul, Fritsch, Norbert, Lamprecht, Bernd, Salzer, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866028/
https://www.ncbi.nlm.nih.gov/pubmed/35223121
http://dx.doi.org/10.1155/2022/1008330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866028/
https://www.ncbi.nlm.nih.gov/pubmed/35223121
http://dx.doi.org/10.1155/2022/1008330

Ejemplares similares